FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007653610> ?p ?o ?g. }

• W2007653610 endingPage "1769" @default.
• W2007653610 startingPage "1761" @default.
• W2007653610 abstract "Objective The increase in blood pressure that accompanies the obese state is almost invariably associated with alterations in metabolism (insulin resistance and dyslipidaemia) and the neurohumoral profile (activation of the renin–angiotensin system, sympathetic overactivity), which potentiate the cardiovascular risk associated with hypertension. However, debate remains as to the antihypertensive drug on which treatment of obesity-related hypertension should be based. The CROSS (Candesartan Role on Obesity and on Sympathetic System) study was undertaken to examine the antihypertensive, neuroadrenergic, and metabolic effects of an angiotensin II receptor blocker in comparison with a diuretic in obese hypertensive individuals. Methods In 127 obese hypertensive individuals aged 50.7 ± 5.1 years (mean ± SD), we measured clinic blood pressure, heart rate, plasma glucose, and insulin at rest and during an oral glucose load before and 12 weeks after treatment with either candesartan cilexetil (8–16 mg once daily) or hydrochlorothiazide (HCTZ, 25–50 mg once daily), administered orally in accordance with a double-blind, randomized, placebo-controlled, two-parallel-groups study design. Insulin sensitivity was expressed as insulin resistance index (IRI), calculated as the ratio of the area under the curve (AUC) for glucose to that for insulin. In a subgroup of patients, measurements also included direct microneurographic recording of muscle sympathetic nerve activity (MSNA) in the peroneal nerve. Results Candesartan cilexetil caused a significant (P< 0.01) reduction in both mean blood pressure (from 114.2 ± 5.1 to 99.6 ± 6.0 mmHg) and MSNA (from 51.0 ± 12.3 to 40.4 ± 12.5 bursts per 100 heart beats), and a significant (P< 0.02) increase in insulin sensitivity (AUC IRI: from −23.2 ± 22.1 to −17.6 ± 12.2). In contrast, HCTZ did not significantly affect MSNA and worsened insulin sensitivity, while achieving blood pressure reductions similar to those produced by candesartan cilexetil. Conclusions These data provide evidence that, in obese hypertensive individuals, treatment with candesartan cilexetil has an antihypertensive effect similar to that of HCTZ. Unlike diuretic treatment, however, treatment with candesartan cilexetil improves insulin sensitivity and exerts sympathoinhibitory effects." @default.
• W2007653610 created "2016-06-24" @default.
• W2007653610 creator A5002176038 @default.
• W2007653610 creator A5010726855 @default.
• W2007653610 creator A5026599670 @default.
• W2007653610 creator A5031410763 @default.
• W2007653610 creator A5037430737 @default.
• W2007653610 creator A5065859301 @default.
• W2007653610 creator A5068301214 @default.
• W2007653610 creator A5084756058 @default.
• W2007653610 date "2003-09-01" @default.
• W2007653610 modified "2023-10-15" @default.
• W2007653610 title "Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals" @default.
• W2007653610 cites W1927710737 @default.
• W2007653610 cites W1979098009 @default.
• W2007653610 cites W1989654418 @default.
• W2007653610 cites W1990801197 @default.
• W2007653610 cites W1992609447 @default.
• W2007653610 cites W2002619263 @default.
• W2007653610 cites W2004949987 @default.
• W2007653610 cites W2008804719 @default.
• W2007653610 cites W2021392889 @default.
• W2007653610 cites W2021976026 @default.
• W2007653610 cites W2025481166 @default.
• W2007653610 cites W2026012644 @default.
• W2007653610 cites W2030030872 @default.
• W2007653610 cites W2038817384 @default.
• W2007653610 cites W2067096633 @default.
• W2007653610 cites W2071693897 @default.
• W2007653610 cites W2088080019 @default.
• W2007653610 cites W2091065554 @default.
• W2007653610 cites W2091678536 @default.
• W2007653610 cites W2091732895 @default.
• W2007653610 cites W2095316629 @default.
• W2007653610 cites W2110713453 @default.
• W2007653610 cites W2114519559 @default.
• W2007653610 cites W2116433329 @default.
• W2007653610 cites W2118313140 @default.
• W2007653610 cites W2126934833 @default.
• W2007653610 cites W2133082625 @default.
• W2007653610 cites W2137335941 @default.
• W2007653610 cites W2151491689 @default.
• W2007653610 cites W2157131266 @default.
• W2007653610 cites W2163584449 @default.
• W2007653610 cites W2170912509 @default.
• W2007653610 cites W2321711947 @default.
• W2007653610 cites W2322154929 @default.
• W2007653610 cites W2324907773 @default.
• W2007653610 cites W2337133379 @default.
• W2007653610 cites W2399839525 @default.
• W2007653610 cites W2418567200 @default.
• W2007653610 cites W4297742559 @default.
• W2007653610 doi "https://doi.org/10.1097/00004872-200309000-00027" @default.
• W2007653610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12923410" @default.
• W2007653610 hasPublicationYear "2003" @default.
• W2007653610 type Work @default.
• W2007653610 sameAs 2007653610 @default.
• W2007653610 citedByCount "211" @default.
• W2007653610 countsByYear W20076536102012 @default.
• W2007653610 countsByYear W20076536102013 @default.
• W2007653610 countsByYear W20076536102014 @default.
• W2007653610 countsByYear W20076536102015 @default.
• W2007653610 countsByYear W20076536102016 @default.
• W2007653610 countsByYear W20076536102017 @default.
• W2007653610 countsByYear W20076536102018 @default.
• W2007653610 countsByYear W20076536102019 @default.
• W2007653610 countsByYear W20076536102020 @default.
• W2007653610 countsByYear W20076536102021 @default.
• W2007653610 countsByYear W20076536102022 @default.
• W2007653610 countsByYear W20076536102023 @default.
• W2007653610 crossrefType "journal-article" @default.
• W2007653610 hasAuthorship W2007653610A5002176038 @default.
• W2007653610 hasAuthorship W2007653610A5010726855 @default.
• W2007653610 hasAuthorship W2007653610A5026599670 @default.
• W2007653610 hasAuthorship W2007653610A5031410763 @default.
• W2007653610 hasAuthorship W2007653610A5037430737 @default.
• W2007653610 hasAuthorship W2007653610A5065859301 @default.
• W2007653610 hasAuthorship W2007653610A5068301214 @default.
• W2007653610 hasAuthorship W2007653610A5084756058 @default.
• W2007653610 hasConcept C126322002 @default.
• W2007653610 hasConcept C134018914 @default.
• W2007653610 hasConcept C2777097880 @default.
• W2007653610 hasConcept C2777391703 @default.
• W2007653610 hasConcept C2778535154 @default.
• W2007653610 hasConcept C2779306644 @default.
• W2007653610 hasConcept C2779918671 @default.
• W2007653610 hasConcept C2780036600 @default.
• W2007653610 hasConcept C2780192228 @default.
• W2007653610 hasConcept C2780361556 @default.
• W2007653610 hasConcept C2908929049 @default.
• W2007653610 hasConcept C71924100 @default.
• W2007653610 hasConcept C84393581 @default.
• W2007653610 hasConceptScore W2007653610C126322002 @default.
• W2007653610 hasConceptScore W2007653610C134018914 @default.
• W2007653610 hasConceptScore W2007653610C2777097880 @default.
• W2007653610 hasConceptScore W2007653610C2777391703 @default.
• W2007653610 hasConceptScore W2007653610C2778535154 @default.
• W2007653610 hasConceptScore W2007653610C2779306644 @default.

• next